Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2557994

IR number 1860329
Words MAZE
Image
Image description
Status protected: Registered/protected
Priority date 21 Oct 2024 (Convention)
Classes 1, 5, 42
Kind Word
Dates
Renewal due 21 Apr 2035
Registration advertised / published 01 Sep 2025
Entered on Register 01 Sep 2025
Acceptance advertised / published 25 Jun 2025
Acceptance 25 Jun 2025
IR notification 19 Jun 2025
Filing 21 Apr 2025
Registered from 21 Apr 2025

Owner Address for service
Maze Therapeutics, Inc.

IR Contact

Joyce Liou of Morrison & Foerster LLP


Goods & Services
Class 1: Diagnostic preparations for scientific or research use other than for medical use; assays and reagents for scientific or medical research use; genetic testing preparations for scientific or medical research use, namely, assays and reagents for use in genetic and biomedical research; cells for scientific or medical research use.
Class 5: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for treating genetic diseases and disorders; pharmaceutical preparations for treating and lysosomal storage disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the reproductive system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention and treatment of obesity; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; reagents for medical use; genetic testing preparations for medical purposes, namely, medical diagnostic reagents and assays for testing of body fluids, cells, and tissue; cells for medical or clinical use; medical diagnostic and testing assays, namely, medical diagnostic reagents and assays for testing of body fluids, cells, and tissue.
Class 42: Pharmaceutical research and development services; research in the field of genetic modifiers and related therapeutics; research in the field of genetic variations linked to medical diseases or conditions; research in the field of variant functionalization.

Convention details
Date 21 Oct 2024
Number 98811175
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image